INsTRuCT Consortium

A network of European scientists from academic and industry focused on developing innovative myeloid regulatory cell (MRC)-based immunotherapies.

INsTRuCT was conceived as a platform for accelerating translation of basic scientific advances in MRC-based therapy into viable pharmaceutical products. The structure of the consortium reflects this ambition, amalgamating excellence in basic, applied and clinical science with expertise from the commercial sector.

The INsTRuCT consortium brings together existing collaborators and several important new partners as a well-balanced and scientifically complementary network.

INsTRuCT Consortium Beneficiaries

Scientist in charge: James Hutchinson, Michael Rehli, Rainer Spang

Scientist in charge: Eva Palsson-Mc Dermott, Zbigniew Zaslona

Scientist in charge: Birgit Sawitzki

Scientist in charge: Silvia Gregori

Scientist in charge: Jordi Ochando

Scientist in charge: Catharien Hilkens, Philipp Lord, John Isaacs

Scientist in charge: Aurélie Moreau, Maria-Cristina Cuturi

Scientist in charge: Wilfred Germeraad

Scientist in charge: Marc Martinez Llordella, Giovanna Lombardi

Scientist in charge: Anja ten Brinke, Marieke van Ham

Scientist in charge: Nathalie Cools

Scientist in charge: Jutta Kollett, Stefan Tomiuk

Scientist in charge: Eva Martinez Cáceres

INsTRuCT Partner Organisation

Main contact: Gabriella Dessole

Main contact: James Malone

Main contact: Miloud Tewfik

Main contact: Nadia Luheshi

Main contact: Jan Schrooten

Main contact: Anne Dickinson, CEO

Main contact: Louise Modis

Main contact: Maria Hernandez-Fuentes

Main contact: Dr. Miguel A. Peinado CSO, Dr. Llorenc Coll, CEO & CTO

Main contact: Thomas Leeuw, Nadine Biesemann

Main contact: Terri Gaskell